ChromaCode’s COVID-19 Test Earns EUA

The FDA has granted an EUA for ChromaCode’s real-time polymerase chain reaction (PCR) COVID-19 test.

The HDPCR SARS-CoV-2 assay uses nasopharyngeal swabs and runs on standard PCR instruments, such as Applied Biosystems’ 7500 Fast, QuantStudio 7 and QuantStudio 12K.

In anticipation of the flu season, the company said that it plans to launch a single test later this year for multiple respiratory viruses, including COVID-19.